Turning Behavioral Segmentation into Actionable Messaging to Increase Adoption in Heart Failure Treatment

Our Challenge: A global pharmaceutical company sought to increase adoption of a heart failure treatment but saw uneven uptake across prescribers. Although segmentation work already existed, teams struggled to translate segment insights into actionable messaging. Different prescriber groups raised distinct objections — such as concerns about patient pushback, treatment complexity, and switching costs — making it unclear how to tailor communication to drive adoption. 

Our Unique Approach: We began by reviewing existing segmentation outputs and prescribing behavior data to understand the psychological and clinical drivers shaping treatment decisions. We then identified and prioritized the key behavioral objections and cognitive biases most predictive of non-adoption across segments. Using these insights, we developed segment-specific messaging strategies aligned to each group's mindset, motivations, and perceived trade-offs, applying behavioral science principles to identify the most effective levers for change. 

Successful Outcomes: The work translated segmentation insights into clear, actionable messaging guidance tailored to distinct prescriber mindsets. Resulting messages proactively addressed segment-specific objections and increased openness to adoption, enabling teams to move from descriptive segmentation to behaviorally informed, targeted communication strategies.